Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Ganga Pharmaceuticals Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Ganga Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Ganga Pharmaceutical - Statement Of Deviation And Variation

    20 May 2025, 8:22PM Statement of Deviation and Variation for March 2025
  • Ganga Pharmaceutical - Results

    20 May 2025, 7:32PM Results for half and year ended March 31, 2025
  • Ganga Pharmaceutical - Board Meeting Outcome for Held On May 20, 2025

    20 May 2025, 7:27PM Outcome of the Board Meeting held on May 20, 2025
  • Ganga Pharmaceutical - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Half

    6 May 2025, 4:19PM Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to conside
  • Ganga Pharmaceutical - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    22 Apr 2025, 5:47PM Resignation of Company Secretary and Compliance Officer
  • Ganga Pharmaceutical - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    22 Apr 2025, 3:09PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Ganga Pharmaceutical has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    21 Apr 2025, 8:00PM As of March 2025, 56.02% is owned by Indian Promoters and 43.98% by Public. <p align=justify> Top five Promoters holding highest number of shares of G
  • Ganga Pharmaceutical - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 3:02PM Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025
  • Ganga Pharmaceutical - Announcement under Regulation 30 (LODR)-Change in Management

    31 Mar 2025, 5:48PM Cessation of Directorship of Mr. Chetan Bhikubhai Patel and Mr. Sachin Chandrakant Chavan due to completion of tenure
  • Ganga Pharmaceutical - Announcement under Regulation 30 (LODR)-Change in Management

    31 Mar 2025, 5:34PM Cessation of Directorship of Mr. Chetan Bhikubhai Patel and Sachin Chandrakant Chavan due to completion of tenure
  • Ganga Pharmaceutical - Announcement under Regulation 30 (LODR)-Change in Directorate

    27 Mar 2025, 3:43PM Appointment of Independent Directors
  • Ganga Pharmaceutical - Board Meeting Outcome for Held On Thursday March 27, 2025

    27 Mar 2025, 3:32PM Outcome of the Board Meeting held on Thursday, March 27, 2025

Key fundamentals

Evaluate the intrinsic value of Ganga Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 8.4105 7.2765 7.2225 6.9315 6.8044
Liabilities 8.4105 7.2765 7.2225 6.9315 6.8044
Equity 4.8365 4.0615 4.0615 4.0615 4.0615
Gross Profit 0.0576 0.0047 0.0421 0.031 0.3864
Net Profit 0.0466 0.0393 0.0378 0.0203 0.1887
Cash From Operating Activities -1.2639 -0.0398 -0.2107 -0.1754 -0.3064
NPM(%) 1.7 1.51 1.52 0.85 6.13
Revenue 2.7357 2.5863 2.489 2.3743 3.0788
Expenses 2.678 2.5816 2.4468 2.3433 2.6923
ROE(%) 0.71 0.6 0.58 0.31 2.89

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Ganga Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 859.90 1.12 28.38 7.60 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.27 -2.54 205.89 27.70 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 26.00 1.13 0.00 57.52 -39.50 0.00
Astec Lifesciences Ltd 806.15 -0.38 0.00 26.12 -687.10 0.00

Company Info

The Company was originally incorporated in Mumbai as "Ganga Pharmaceuticals Private Limited" on 11th September, 1989 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Mumbai. The Company was converted in to a Public Limited Company and consequently the name was changed to "Ganga Pharmaceuticals Private Limited" vide fresh certificate of incorporation dated 19th September, 1994 issued by the Registrar of Companies, Mumbai. The CIN No. of the Company is U99999MH1989PLC053392. The Company was set up by Late Shri Brijmohan Sharma, a qualified Ayurveda visionary in the year 1974 as a proprietary concern. In the year 1989, the proprietary firm was converted to a Private Limited Company and subsequently converted in to a Public Limited Company as on 19th September, 1994. The Company was established as a producer of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Under the Management of Late Shri Brijmohan Sharma, the Company had created an exceptional market reputation not only in Mumbai but all over Maharashtra. Initially, the company was manufacturing the following proprietary products: 1) Ampachan Vati; 2) Khadira Vati; 3) Nirmalaya churna Bearing in mind, the growing demand for the above products and newer products, increasing market share in Bulk Ayurvedic Medicine Sector and need for expertise in the business; Mr. Bharat Brijmohan Sharma, son of Late Shri Brijmohan Sharma took over the business. Being a Bachelor of Pharmacy from Pune University and a technocrat having rich experience in production and management of Ayurvedic unit, he not only extended the business to the neighbouring states but also introduced newer products within the company. As on date the company, it has 230 number of products in its total portfolio. We have been awarded a G.M.P Certification for following Good Manufacturing Practices under Revised Schedule T of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, Pills, Oils, Syrups and Powder based products by Food & Drug Administration, Maharashtra. Further, The company is characterized as Small Scale Industrial Unit by registering with the Directorate of Industries, Maharashtra. Key Events and Milestones: The following table sets forth the key events and milestones in the history of our Company, since incorporation: 1993 - Expanded the product portfolio to the current portfolio in 20 years 1993 - Obtained Import-Export License 2000 - Created and Developed Ayurvedic Pharmacopeias- a in-house guideline to be followed from manufacturing stage to packaging stage 2000 - Set up full fledge in-house Laboratory with the Manufacturing Unit 2001 - Received Good Manufacturing Practice (GMP) Certificate from FDA, Maharashtra 2004 - Established C & F depots in West Bengal & Orissa 2009 -`High Performance Capability and Moderate Financial Strength' Certificate received from NSICCRISIL

The Company was originally incorporated in Mumbai as "Ganga Pharmaceuticals Private Limited" on 11th September, 1989 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Mumbai. The Company was converted in to a Public Limited Company and consequently the name was changed to "Ganga Pharmaceuticals Private Limited" vide fresh certificate of incorporation dated 19th September, 1994 issued by the Registrar of Companies, Mumbai. The CIN No. of the Company is U99999MH1989PLC053392. The Company was set up by Late Shri Brijmohan Sharma, a qualified Ayurveda visionary in the year 1974 as a proprietary concern. In the year 1989, the proprietary firm was converted to a Private Limited Company and subsequently converted in to a Public Limited Company as on 19th September, 1994. The Company was established as a producer of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Under the Management of Late Shri Brijmohan Sharma, the Company had created an exceptional market reputation not only in Mumbai but all over Maharashtra. Initially, the company was manufacturing the following proprietary products: 1) Ampachan Vati; 2) Khadira Vati; 3) Nirmalaya churna Bearing in mind, the growing demand for the above products and newer products, increasing market share in Bulk Ayurvedic Medicine Sector and need for expertise in the business; Mr. Bharat Brijmohan Sharma, son of Late Shri Brijmohan Sharma took over the business. Being a Bachelor of Pharmacy from Pune University and a technocrat having rich experience in production and management of Ayurvedic unit, he not only extended the business to the neighbouring states but also introduced newer products within the company. As on date the company, it has 230 number of products in its total portfolio. We have been awarded a G.M.P Certification for following Good Manufacturing Practices under Revised Schedule T of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, Pills, Oils, Syrups and Powder based products by Food & Drug Administration, Maharashtra. Further, The company is characterized as Small Scale Industrial Unit by registering with the Directorate of Industries, Maharashtra. Key Events and Milestones: The following table sets forth the key events and milestones in the history of our Company, since incorporation: 1993 - Expanded the product portfolio to the current portfolio in 20 years 1993 - Obtained Import-Export License 2000 - Created and Developed Ayurvedic Pharmacopeias- a in-house guideline to be followed from manufacturing stage to packaging stage 2000 - Set up full fledge in-house Laboratory with the Manufacturing Unit 2001 - Received Good Manufacturing Practice (GMP) Certificate from FDA, Maharashtra 2004 - Established C & F depots in West Bengal & Orissa 2009 -`High Performance Capability and Moderate Financial Strength' Certificate received from NSICCRISIL

Read More

Parent Organisation

Ganga Pharmaceuticals Ltd.

Founded

11/09/1989

Managing Director

Mr.Bharat Brijmohan Sharma

NSE Symbol

FAQ

The current price of Ganga Pharmaceuticals Ltd is

The 52-week high for Ganga Pharmaceuticals Ltd is

The market capitalization of Ganga Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Ganga Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Ganga Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Ganga Pharmaceuticals Ltd shares.

The CEO of Ganga Pharmaceuticals Ltd is Mr.Bharat Brijmohan Sharma, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT